$ISWH Home Health Care is in a boom and ISWH is demonstrating tangible financial performance in the space, leading to EBITDA profitability and 6,400% sales growth. That defines the company’s Q2 and Q3 of 2019. And Q4 is likely going to be another major growth statement from this division.

Home health spending is expected increase at a faster rate through 2027 than all other categories of care, according to a recent analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary.

Home health care spending is expected to reach more than $186 billion in 2027, according to the report. This is miles above any other category of health care service, including hospital inpatient care, physician and professional services, nursing facilities, prescription drugs, retail sales of medical products and literally everything else in the space.

While the company has a legacy spirits segment that promises to generate strong growth in Q4, and a powerful potential as a CBD products brand in 2020, the lion’s share of the topline jump we have seen over the past two quarters has actually come from its Home Healthcare segment. Continues to See Dramatic Expansion as a Home Healthcare Leader https://www.wallstreetpr.com/iswh-continues-t...ader-42681